MEDS ▲ +64.4% - DataMEDS AI, Inc. $MEDS AGPU - DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute DataMEDS AI surged 64.4% today following its acquisition of Helomics, an AI-powered cancer diagnostics lab and precision oncology contract research organization, from Axe Compute. The deal expands DataMEDS's capabilities in artificial intelligence-driven oncology services, combining diagnostic and clinical research operations under one platform. 15-SEP-2026 04:05 PM ET